Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed ... employing around 7,000 employees, with Amgen, GSK, Pfizer, AbbVie, MSD, Novartis, and ...

The company also announced an expansion of its Singapore manufacturing facility in 2024 ... demographic shift toward an older population, Amgen, a biotech stalwart, is emphasizing the importance ...

Singapore is a hot spot of manufacturing for the biopharma and ... home to 14 companies employing around 7,000 employees, with Amgen, GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

Genesis MedTech has successfully completed its first robotic-assisted surgeries, marking a significant milestone in surgical innovation. The procedures, performed at Clínica Andes Salud Concepción in ...

Healthcare giants such as AbbVie ABBV, Amgen AMGN, Stryker SYK and Dexcom ... The company also announced an expansion of its Singapore manufacturing facility in 2024. This investment aims to ...

Amgen ( NASDAQ: AMGN) shares snapped six straight sessions of gains, as the stock ended 3% lower at $306.2 on Wednesday. The biotechnology company gained 7.8% in the preceding six sessions. The stock ...

Amgen today announced that its Board of Directors declared a $2.38 per share dividend for the second quarter of 2025. The dividend will be paid on June 6, 2025, to all stockholders of record as of the ...

Upcoming patent losses are looming large for a number of pharma giants, including Amgen. The company reported ... of our differentiating capabilities is manufacturing large proteins, particularly ...

Amgen discovers, develops ... difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political ...